Compounds > fluorobenzenes
Page last updated: 2024-08-21

fluorobenzenes and Ischemic Attack, Transient

fluorobenzenes has been researched along with Ischemic Attack, Transient in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busija, DW; Domoki, F; Gáspár, T; Katakam, PV; Mayanagi, K1
Ghani, U; Mohammad, A; Schwindt, B; Shuaib, A1
Doerfler, A; Engelhorn, T; Heusch, G; Schulz, R1

Other Studies

4 other study(ies) available for fluorobenzenes and Ischemic Attack, Transient

ArticleYear
Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2008, Volume: 28, Issue:12

    Topics: Animals; Blood Glucose; Blotting, Western; Cerebrovascular Circulation; Cholesterol; Disease Models, Animal; Endothelium, Vascular; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Ischemic Attack, Transient; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Nitric Oxide Synthase; Obesity; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Time Factors

2008
Endothelial progenitor cells in patients with acute cerebrovascular ischemia.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2010, Volume: 37, Issue:6

    Topics: Aged; Cell Count; Endothelial Cells; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Statistics, Nonparametric; Stem Cells; Sulfonamides; Time Factors

2010
Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.
    Neuroscience letters, 2006, Oct-02, Volume: 406, Issue:1-2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Cerebral Infarction; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enzyme Activation; Enzyme Inhibitors; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Tetrazoles; Treatment Outcome

2006
Atorvastatin for stroke prevention.
    The Medical letter on drugs and therapeutics, 2006, Sep-11, Volume: 48, Issue:1243

    Topics: Atorvastatin; Cerebral Hemorrhage, Traumatic; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Muscular Diseases; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Stroke; Sulfonamides; Time Factors

2006